KZR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Kezar Life Sciences Inc (KZR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a neutral to slightly bullish trend, but the lack of positive financial performance, absence of significant news catalysts, and no strong trading signals suggest holding off on investment for now.
The MACD histogram is slightly positive at 0.0515, indicating mild bullish momentum. The RSI is neutral at 65.758, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level (6.556) with key resistance at 6.804 and support at 6.308.
Bullish moving averages and slightly positive MACD indicate mild upward momentum. The low put-call ratios suggest limited bearish sentiment.
No significant news or events in the past week. Financial performance is weak, with a significant drop in net income (-44.73% YoY) and EPS (-94.50% YoY). No recent congress trading data or analyst rating updates.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$11.23 million (-44.73% YoY), and EPS fell sharply by -94.50% YoY to -1.53. Gross margin remained unchanged at 0.
No recent analyst rating or price target updates available.
